BERLIN, Feb 7 (Reuters) - Swiss pharmaceutical company Roche said on Saturday its experimental multiple sclerosis drug ...

RIVERSIDE, N.J. (WPVI) -- A multiple sclerosis diagnosis used to mean a future of disability. But now, a revolution in medications allows MS patients to pursue their dreams. Those medications are ...

A small study found MS patients reported improved quality of life and reduced depression after Ocrelizumab biosimilar treatment ...

Even women with more severe MS cases are less likely than men to get critical treatments, a new study finds. Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

The risk for colorectal cancer is increased in patients with multiple sclerosis (MS) taking mitoxantrone, a new study suggests. "We found that mitoxantrone may moderately increase the risk of ...

Add Yahoo as a preferred source to see more of our stories on Google. Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

Appealing an insurance claim denial with multiple sclerosis often requires following the rules and being persistent.